Skip to content

Bolt Biotherapeutics, Inc.: filings

Every Bolt Biotherapeutics, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 22 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-11fiscal Q2 2026411120001193125-26-344597
10-Q2026-05-12fiscal Q1 202640820001193125-26-219382
10-K2026-03-12fiscal FY 202544880001193125-26-104121
10-Q2025-11-12fiscal Q3 2025411120001193125-25-277549
10-Q2025-08-14fiscal Q2 2025401100001641281-25-000007
10-Q2025-05-12fiscal Q1 202539800000950170-25-069188
10-K2025-03-24fiscal FY 202443860000950170-25-043873
10-Q2024-11-12fiscal Q3 2024411120000950170-24-125413
10-Q2024-08-13fiscal Q2 2024411120000950170-24-096200
10-Q2024-05-14fiscal Q1 202439800000950170-24-059564
10-K2024-03-21fiscal FY 202343860000950170-24-034692
10-Q2023-11-09fiscal Q3 2023411120000950170-23-062048
10-Q2023-08-07fiscal Q2 2023411120000950170-23-039061
10-Q2023-05-11fiscal Q1 202341820000950170-23-021233
10-K2023-03-29fiscal FY 202244870000950170-23-010613
10-Q2022-11-10fiscal Q3 2022411120000950170-22-024487
10-Q2022-08-10fiscal Q2 202238980000950170-22-016460
10-Q2022-05-12fiscal Q1 202238770000950170-22-009664
10-K2022-03-30fiscal FY 202140790000950170-22-005047
10-Q2021-11-09fiscal Q3 202138980001564590-21-055774
10-Q2021-08-12fiscal Q2 202138990001564590-21-044002
10-Q2021-05-13fiscal Q1 202138760001564590-21-027545

Inspect the source

Entity
Bolt Biotherapeutics, Inc. / CIK 0001641281
Captured
2026-09-21T17:22:27.349Z
SEC response SHA-256
0f6383c139bc967418d7cb627e00bbaa74f12b147973818c18daaed16688a891

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001641281.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))